Eli Lilly, one of the leading manufacturers of insulin, announced they are slashing the price of their most commonly prescribed insulin, by 70 percent. The company is capping the out-of-pocket price for insured patients at $35.
source
Eli Lilly, one of the leading manufacturers of insulin, announced they are slashing the price of their most commonly prescribed insulin, by 70 percent. The company is capping the out-of-pocket price for insured patients at $35.
source